Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2013 · 10-Q
Revenue$86.48M$86.48M−4.9% vs Q3 2012 Net Income$5.67M$5.67M−21.3% vs Q3 2012 EPS Diluted$0.41$0.41−21.2% vs Q3 2012 Gross Profit$64,853,000−5.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,376,000−23.0% Free Cash Flowderived$3,309,000−46.5% Margins · derivedGross margin75.0%−0.1 pt vs Q3 2012
Operating margin8.5%−1.3 pt vs Q3 2012
Net margin6.6%−1.4 pt vs Q3 2012
ended Sep 30, 2013 · filed Nov 12, 2013 · 43 d after period end